Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
The major cause of mortality in patients with cystic fibrosis (CF) is lung disease. Expression of the cystic fibrosis transmembrane conductance regulator (CFTR) gene product in the airways is a potential treatment. Clinical studies in which the CFTR cDNA was delivered to the respiratory epithelia of...
Main Authors: | Hyde, S, Southern, K, Gileadi, U, Fitzjohn, E, Mofford, K, Waddell, B, Gooi, H, Goddard, C, Hannavy, K, Smyth, SE, Egan, J, Sorgi, F, Huang, L, Cuthbert, A, Evans, M, Colledge, W, Higgins, C, Webb, A, Gill, DR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
by: Gill, DR, et al.
Published: (1997) -
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
by: Hyde, S, et al.
Published: (1993) -
Apical CFTR expression in human nasal epithelium correlates with lung disease in cystic fibrosis.
by: Marit Arianne van Meegen, et al.
Published: (2013-01-01) -
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
by: Gill, DR, et al.
Published: (2001) -
Aerosol delivery of DNA/liposomes to the lung for cystic fibrosis gene therapy.
by: Davies, L, et al.
Published: (2014)